Rein Therapeutics Inc (RNTX) Stock Price, Quote & News

Company Profile

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The com...

Industry: Biotechnology

Sector: Healthcare

Phone: 737 802 1989

Website: www.reintx.com

Address:

12407 N. Mopac Expy., Suite 250 #390, Austin, United States

BrianWindsor Mar. 19 at 3:52 PM

A lot of people ask me where the name Rein Therapeutics comes from. We want to rein in fibrosis, a devastating lung disease that still has very limited treatment options. I explain the story behind the name, and our Austin roots, in this short video.` https://youtu.be/evQmTjT4s7w $RNTX

0 · Reply

MomentumWins Mar. 16 at 6:50 PM

$RNTX Just asked grok what is the market potential if all goes well.. RnTx can reach 3B from current 32M. if ALL goes well ⭐️⭐️

0 · Reply

suredubb Mar. 13 at 12:03 AM

$RNTX lots of buying today MMs took it back to yesterday’s high, but this stock wants to go up

0 · Reply

suredubb Mar. 13 at 12:00 AM

$RNTX investor meetings must have gone well in NYC… huge increase in volume and big price spikes today multiple times.. probably folks making personal buys… i’m sure their firms will be making big investments soon.. good time to scale in early

0 · Reply

BrianWindsor Mar. 12 at 7:22 PM

Just wrapped up a productive NYC trip meeting with both existing and new investors. Appreciate the time and thoughtful questions about what we’re building at Rein. Much more productive than my Boston visit during the blizzard two weeks ago! $RNTX

0 · Reply

suredubb Mar. 12 at 3:49 PM

$RNTX i love bio companies in this stage of drug development RNTX is far along.. endorsed in Europe so far as well.. can’t believe it’s not $5 or more chart looks great.. awesome time to scale in.. volatile, but so much fun getting in early University of Texas a big investor

0 · Reply

wolfcyd3 Mar. 11 at 5:14 PM

$RNTX wants to take off

0 · Reply

MomentumWins Mar. 10 at 5:56 PM

$RNTX by october 30$ or 50 cents ?? results due in second half

0 · Reply

BioTuesdays Mar. 3 at 5:31 PM

$RNTX has announced that the first patient has been dosed in its Phase 2 clinical trial evaluating LTI-03 for idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease with limited treatment options. https://biotuesdays.com/2026/03/03/rein-doses-first-patient-in-phase-2-trial-of-lti-03-in-ipf/

0 · Reply

BrianWindsor Mar. 3 at 2:11 PM

First patient officially dosed in our Phase 2 trial of LTI-03 for IPF. This follows FDA clearance to resume the program and marks an important step in advancing our lead asset. Randomized, placebo-controlled study. ~120 patients. Interim data expected in 2H 2026. Appreciate everyone following our progress as we execute! $RNTX #IPF https://www.youtube.com/shorts/00BmERCURu4

0 · Reply

Why Is Rein Therapeutics Stock Trading Higher On Monday?

Oct 9, 2025, 7:30 AM EDT - 5 months ago

Rein Therapeutics Receives European Regulatory Approval to Initiate Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Sep 17, 2025, 7:30 AM EDT - 6 months ago

Rein Therapeutics Announces Publication of New Translational Data in iScience on Company's Novel Therapy for Idiopathic Pulmonary Fibrosis

Aug 19, 2025, 8:00 AM EDT - 7 months ago

Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Aug 14, 2025, 5:00 PM EDT - 7 months ago

Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025

Jun 24, 2025, 10:11 AM EDT - 9 months ago

Rein Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Jun 12, 2025, 5:18 PM EDT - 10 months ago

US FDA puts on hold Rein Therapeutics' lung disease drug trial

May 27, 2025, 7:00 AM EDT - 10 months ago

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF

IQV

May 19, 2025, 4:51 PM EDT - 10 months ago

Rein Therapeutics Presents Two Posters at the American Thoracic Society 2025 International Conference

May 15, 2025, 4:09 PM EDT - 11 months ago

Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025, 7:00 AM EDT - 11 months ago

Rein Therapeutics Announces Initiation of RENEW Phase 2 Trial of LTI-03 in Patients with IPF

May 1, 2025, 7:00 AM EDT - 11 months ago

Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF

Apr 30, 2025, 4:05 PM EDT - 11 months ago

Rein Therapeutics to Present at The Citizens Life Sciences Conference 2025

Apr 28, 2025, 7:00 AM EDT - 11 months ago

Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference

Apr 23, 2025, 7:00 AM EDT - 11 months ago

Rein Therapeutics Granted Two Patents Covering the Novel Formulation and Administration Methods of Dry Powder LTI-03 for the Treatment of Respiratory Diseases

Apr 15, 2025, 7:00 AM EDT - 1 year ago

Rein Therapeutics Announces a Publication in Biomedicines on the Immunomodulatory and Anti-fibrotic Properties of a Caveolin-1-Related Peptide in IPF and PASC-F

Apr 7, 2025, 4:17 PM EDT - 1 year ago

Rein Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

BrianWindsor Mar. 19 at 3:52 PM

0 · Reply

MomentumWins Mar. 16 at 6:50 PM

$RNTX Just asked grok what is the market potential if all goes well.. RnTx can reach 3B from current 32M. if ALL goes well ⭐️⭐️

0 · Reply

suredubb Mar. 13 at 12:03 AM

$RNTX lots of buying today MMs took it back to yesterday’s high, but this stock wants to go up

0 · Reply

suredubb Mar. 13 at 12:00 AM

0 · Reply

BrianWindsor Mar. 12 at 7:22 PM

0 · Reply

suredubb Mar. 12 at 3:49 PM

0 · Reply

wolfcyd3 Mar. 11 at 5:14 PM

$RNTX wants to take off

0 · Reply

MomentumWins Mar. 10 at 5:56 PM

$RNTX by october 30$ or 50 cents ?? results due in second half

0 · Reply

BioTuesdays Mar. 3 at 5:31 PM

0 · Reply

BrianWindsor Mar. 3 at 2:11 PM

0 · Reply

OfficialStocktwitsUser Feb. 26 at 2:10 PM

$RNTX RSI: 52.00, MACD: -0.0242 Vol: 0.11, MA20: 1.22, MA50: 1.25 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply